Emollient treatment of atopic dermatitis: latest evidence and clinical considerations

Aim: To review current classes of emollients in the market, their clinical efficacy in atopic dermatitis (AD) and considerations for choice of an emollient. Methods: PubMed Clinical Queries under Clinical Study Categories (with Category limited to Therapy and Scope limited to Narrow) and Systemat...

Full description

Bibliographic Details
Main Authors: Kam Lun Hon, Jeng Sum Charmaine Kung, Wing Gi Gigi Ng, Ting Fan Leung
Format: Article
Language:English
Published: BioExcel Publishing Ltd 2018-04-01
Series:Drugs in Context
Subjects:
Online Access:http://www.drugsincontext.com/emollient-treatment-of-atopic-dermatitis-latest-evidence-and-clinical-considerations
Description
Summary:Aim: To review current classes of emollients in the market, their clinical efficacy in atopic dermatitis (AD) and considerations for choice of an emollient. Methods: PubMed Clinical Queries under Clinical Study Categories (with Category limited to Therapy and Scope limited to Narrow) and Systematic Reviews were used as the search engine. Keywords of ‘emollient or moisturizer’ and ‘atopic dermatitis’ were used. Overview of findings: Using the keywords of ‘emollient’ and ‘atopic dermatitis’, there were 105 and 36 hits under Clinical Study Categories (with Category limited to Therapy and Scope limited to Narrow) and Systematic Reviews, respectively. Plant-derived products, animal products and special ingredients were discussed. Selected proprietary products were tabulated. Conclusions: A number of proprietary emollients have undergone trials with clinical data available on PubMed-indexed journals. Most moisturizers showed some beneficial effects, but there was generally no evidence that one moisturizer is superior to another. Choosing an appropriate emollient for AD patients would improve acceptability and adherence for emollient treatment. Physician’s recommendation is the primary consideration for patients when selecting a moisturizer/ emollient; therefore, doctors should provide evidence-based information about these emollients.
ISSN:1740-4398
1740-4398